Tag: DSM

ABLC buzzes about finance, government actions, chemicals, carbon, and technology advances

ABLC buzzes about finance, government actions, chemicals, carbon, and technology advances

April 23, 2014 |

As ABLC completes its second day, companies, agencies, financiers step forward to detail advances toward scale, new programs. In Washington, more than 35 companies came under the microscope as delegates at ABLC, the annual bioeconomy leadership conference which continues through Wednesday with more than 100 speakers on the agenda, moved from policy considerations to a […]

Read More

10 Bellwether Biofuels & Biobased Projects for 2014

10 Bellwether Biofuels & Biobased Projects for 2014

April 14, 2014 |

Advanced biofuels – are plans turning into reality? Are development plans realistic? When these 10 projects open for business (or not) in 2014, you’ll know for sure. We wrote in 2012: “If, by this time next year, we have all of these projects completed and in operation, it will go a long way towards substantiating […]

Read More

DSM expects POET plant to produce cellulosic ethanol from July

DSM expects POET plant to produce cellulosic ethanol from July

April 3, 2014 |

In Iowa, DSM expects to begin producing cellulosic ethanol at its $250 million joint venture demo facility with POET in Emmetsburg in July. The companies expect to produce 12 million gallons this year and up to 25 million gallons from next year. The EPA says it expects to announce its RFS blending requirements, including cellulosic […]

Read More

DSM Bio-based Products & Services: Biofuels Digest’s 2014 5-Minute Guide

DSM Bio-based Products & Services: Biofuels Digest’s 2014 5-Minute Guide

March 19, 2014 |

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences, DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such […]

Read More

2014 may spell resurgance for private investment in renewable chemicals

2014 may spell resurgance for private investment in renewable chemicals

January 6, 2014 |

According to Green Chemicals Blog, 2014 may see a resurgence of private investment in renewable chemicals as traditional chemical companies including DSM, BASF, DuPont, Braskem, Dow, and more turn toward investment in several commercially-viable biobased chemicals. Recent financing announcements from Amyris, Calysta Energy, Global Bioenergies, Saudi Aramco Energy Ventures, and more support this assertion. The […]

Read More

DSM and Natuurmonumenten lay the foundations for biomass cooperation in the Netherlands

DSM and Natuurmonumenten lay the foundations for biomass cooperation in the Netherlands

December 17, 2013 |

In the Netherlands, DSM and Natuurmonumenten (Society for the Preservation of Nature in the Netherlands) are together looking for a partner who is willing to use the biomass generated from the nature-reserve maintenance activities of Natuurmonumenten as a raw material in the production of, for example, renewable fuels and bio-based materials. The signing of the […]

Read More

DSM joins LIPA-Team to develop series production of advanced thermoplastic composites parts

DSM joins LIPA-Team to develop series production of advanced thermoplastic composites parts

November 7, 2013 |

In Singapore, DSM has has joined the LIPA-Team, set up to develop an industrial process for the manufacture of endless-fiber-reinforced advanced thermoplastic composite parts. LIPA stands for “Lightweight Integrated Process Application”. DSM will contribute with materials know-how and in-depth understanding of polyamide 6 applications. DSM is launching a range of carbon fiber reinforced composites based […]

Read More

DSM announces repurchase of shares to cover existing option plans

DSM announces repurchase of shares to cover existing option plans

November 6, 2013 |

In the Netherlands, Royal DSM announced that it intends to repurchase 2,500,000 ordinary shares, starting on 6 November 2013, in order to cover its commitments under existing management and personnel option plans. Based on the closing price of the DSM share on NYSE Euronext on 5 November 2013 this would be equivalent to approximately €140 […]

Read More

DSM Venturing makes strategic investment in ChromaDex

DSM Venturing makes strategic investment in ChromaDex

October 28, 2013 |

In the Netherlands, DSM Venturing, the corporate venture arm of Royal DSM has provided equity financing to ChromaDex Corp. ChromaDex describes itself as an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries. Frank Jaksch, Jr., CEO and co-founder of […]

Read More

DSM gives Genomatica’s biobased BDO two thumbs up

DSM gives Genomatica’s biobased BDO two thumbs up

October 9, 2013 |

In California and Singapore, Royal DSM and Genomatica announced that DSM confirmed BDO made with Genomatica’s process had excellent purity and shows equivalent performance as fossil-based BDO. DSM plans to use BDO made with Genomatica’s bio-based process technology in its Arnitel products. Used as a raw material, BDO made from Genomatica’s process is able to […]

Read More